Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00416221 · ClinicalTrials.gov registry record · NA
PACEPro - Mood Management Pilot
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00416221: Completed NA study, sponsored by University of California, San Diego.
NCT00416221 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00416221, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing: Lexapro, an antidepressant medicine…Learn More Physical activity information and pedometer Mood management skills and a Mood Mastery Guide Personalized support from a Family Nurse Practitioner
Interventions
- BEHAVIORAL Physical Activity
- DRUG Lexapro, an antidepressant medicine
- BEHAVIORAL Mood Management Skills
- BEHAVIORAL Personalized support from a Family Nurse Practitioner
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-04 |
| Est. Completion | 2007-01 |
| Phase | NA |
What the finished NCT00416221 record still lists
NCT00416221 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Physical Activity is the first listed.
NCT00416221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00416221 about?
NCT00416221 is a clinical study titled "PACEPro - Mood Management Pilot". Researchers at the University of California at San Diego (UCSD) are conducting a 12-week study to test the PACEPRO program. This program is designed to reduce depression by providing: Lexapro, an antidepressant medicine…Learn More Physical activity information and pedometer Mood management skills a...
What is the current status of trial NCT00416221?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2006-04. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00416221?
The interventions under investigation include: Physical Activity (BEHAVIORAL), Lexapro, an antidepressant medicine (DRUG), Mood Management Skills (BEHAVIORAL), Personalized support from a Family Nurse Practitioner (BEHAVIORAL).
Who is sponsoring clinical trial NCT00416221?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00416221's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia